Granules India Gets USFDA Nod for ADHD Treatment
January 30, 2025 14:05
Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children.